Comparison of high and low doses of captopril in congestive heart failure (CHF) with left to right shunt
Phase 2
- Conditions
- congenital heart disease.Congenital malformation of cardiac chambers and connections, unspecified
- Registration Number
- IRCT2012072910441N1
- Lead Sponsor
- Shiraz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
congenital heart disease with left to right shunt. Exclusion criteria: Trisomy 21, congenital anomalies including cleft lip and cleft palate esophageal atresia.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of captopril. Timepoint: The first, third and 7th day of treatment. Method of measurement: Rose score, Echocardiography.
- Secondary Outcome Measures
Name Time Method Serum Renin and Aldostron. Timepoint: The 7th day. Method of measurement: Renin and Aldostron level and Echocardiography.